File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

홍성유

Hong, Sung You
Synthetic Organic Chemistry Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Development of P22 Viral Capsid Nanocomposites as Anti-Cancer Drug, Bortezomib (BTZ), Delivery Nanoplatforms

Author(s)
Min, JunseonMoon, HyojinYang, Hyun JiShin, Hyun-HeeHong, Sung YouKang, Sebyung
Issued Date
2014-04
DOI
10.1002/mabi.201300401
URI
https://scholarworks.unist.ac.kr/handle/201301/3983
Fulltext
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84898814876
Citation
MACROMOLECULAR BIOSCIENCE, v.14, no.4, pp.557 - 564
Abstract
Genetic and chemical engineering approaches are used to employ P22 viral capsids as nanoplatforms for developing an efficient delivery vehicle. Catechol ligands are chemically attached to the interior surface of P22 viral capsid for subsequent encapsulation of an anticancer drug, bortezomib (BTZ), through boronic acid-diol complexation. For targeted delivery, hepatocellular carcinoma (HCC)-targeting peptide (SP94, SFSIIHTPILPL) is synthesized and chemically conjugated to the exterior surface of the P22 viral capsid nanocomposites. Effective targeted delivery of synthesized P22 viral capsid nanocomposites is demonstrated by fluorescent cell imaging and the efficacy of delivered P22 viral capsid nanocomposites is evaluated using a cell viability assay.
Publisher
WILEY-V C H VERLAG GMBH
ISSN
1616-5187

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.